Importer of Controlled Substances; Notice of Registration; Cerilliant Corporation, 31389 [2012-12826]
Download as PDF
<![CDATA[
31389
Federal Register / Vol. 77, No. 102 / Friday, May 25, 2012 / Notices
be registered as an importer of
Morphine (9300), a basic class of
controlled substance listed in schedule
II.
The company manufactures a product
containing morphine in the United
States. The company exports this
product to customers around the world,
including Europe. The company has
been asked to ensure that its product
sold to European customers meets
standards established by the European
Pharmacopeia, which is administered
by the Directorate of the Quality of
Medicines (EDQM). In order to ensure
that its product will meet European
specifications, the company seeks to
import morphine supplied by EDQM to
use as reference standards. This is the
sole purpose for which the company
will be authorized by DEA to import
morphine.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Meridian Medical Technologies to
import the basic class of controlled
substance is consistent with the public
interest and with United States
obligations under international treaties,
conventions, or protocols in effect on
May 1, 1971. DEA has investigated
Meridian Medical Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic class of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Schedule
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Poppy Straw Concentrate (9670)
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substance
intermediates for sale to its customers.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(2007)
DEA has considered the factors in 21
U.S.C. 823(a) and 952(a), and
determined that the registration of
Penick Corporation to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Penick Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12830 Filed 5–24–12; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2012–12813 Filed 5–24–12; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
mstockstill on DSK4VPTVN1PROD with NOTICES
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Penick
Corporation
By Notice dated April 17, 2012 and
published in the Federal Register on
April 26, 2012, 77 FR 24983, Penick
Corporation, 33 Industrial Park Road,
VerDate Mar<15>2010
17:55 May 24, 2012
Jkt 226001
Importer of Controlled Substances;
Notice of Registration; Cerilliant
Corporation
By Notice dated March 8, 2012, and
published in the Federal Register on
March 20, 2012, 77 FR 16261, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402, made
application by letter to the Drug
Enforcement Administration (DEA) to
PO 00000
Frm 00100
Fmt 4703
Sfmt 9990
be registered as an importer of the
following basic classes of controlled
substances:
Drug
4-methyl-N-methylcathinone
(1248).
1-Pentyl-3-(1-naphthoyl)indole
(7118).
1-Butyl-3-(1-naphthoyl)
indole
(7173).
1-[2-(4-Morpholinyl)-ethyl}-3-(1naphthoyl)indole (7200).
5-(1,1-Dimethylheptyl)-2-{(1R,3S)3-hydroxycyclohexyl]-phenol
(7297).
5-(1,1-Dimethyloctyl)-2[(1R,3S)-3hydroxycyclohexyl]
phenol
(7298).
3,4-methylenedioxypyrovalerone
(7535).
3,4-methylenedioxy-Nmethylcathinone (7540).
Desomorphine (9055) ...................
Schedule
I
I
I
I
I
I
I
I
I
The company plans to import small
quantities of the listed controlled
substances for the manufacture of
analytical reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
and determined that the registration of
Cerilliant Corporation to import the
basic classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. DEA
has investigated Cerilliant Corporation
to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–12826 Filed 5–24–12; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\25MYN1.SGM
25MYN1
]]>Agencies
[Federal Register Volume 77, Number 102 (Friday, May 25, 2012)]
[Notices]
[Page 31389]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-12826]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Cerilliant Corporation
By Notice dated March 8, 2012, and published in the Federal
Register on March 20, 2012, 77 FR 16261, Cerilliant Corporation, 811
Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application
by letter to the Drug Enforcement Administration (DEA) to be registered
as an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
4-methyl-N-methylcathinone (1248).......... I
1-Pentyl-3-(1-naphthoyl)indole (7118)...... I
1-Butyl-3-(1-naphthoyl) indole (7173)...... I
1-[2-(4-Morpholinyl)-ethyl{time} -3-(1- I
naphthoyl)indole (7200).
5-(1,1-Dimethylheptyl)-2-{(1R,3S)-3- I
hydroxycyclohexyl]-phenol (7297).
5-(1,1-Dimethyloctyl)-2[(1R,3S)-3- I
hydroxycyclohexyl] phenol (7298).
3,4-methylenedioxypyrovalerone (7535)...... I
3,4-methylenedioxy-N-methylcathinone (7540) I
Desomorphine (9055)........................ I
------------------------------------------------------------------------
The company plans to import small quantities of the listed
controlled substances for the manufacture of analytical reference
standards.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Cerilliant Corporation to import the basic classes of
controlled substances is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. DEA has investigated Cerilliant
Corporation to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: May 15, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-12826 Filed 5-24-12; 8:45 am]
BILLING CODE 4410-09-P
